Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$31.15 - $33.39 $35,666 - $38,231
1,145 Added 1.84%
63,347 $2.1 Million
Q3 2022

Nov 14, 2022

SELL
$30.9 - $33.55 $9,795 - $10,635
-317 Reduced 0.51%
62,202 $1.96 Million
Q2 2022

Aug 12, 2022

BUY
$23.75 - $31.69 $187,031 - $249,558
7,875 Added 14.41%
62,519 $1.9 Million
Q1 2022

May 11, 2022

BUY
$19.97 - $26.94 $109,096 - $147,173
5,463 Added 11.11%
54,644 $1.42 Million
Q4 2021

Feb 07, 2022

BUY
$17.46 - $21.61 $89,517 - $110,794
5,127 Added 11.64%
49,181 $1 Million
Q3 2021

Nov 10, 2021

BUY
$17.35 - $22.5 $85,882 - $111,375
4,950 Added 12.66%
44,054 $848,000
Q2 2021

Aug 05, 2021

BUY
$18.01 - $28.32 $157,173 - $247,148
8,727 Added 28.73%
39,104 $867,000
Q1 2021

May 14, 2021

BUY
$19.76 - $29.89 $155,432 - $235,114
7,866 Added 34.94%
30,377 $797,000
Q4 2020

Feb 12, 2021

BUY
$15.73 - $21.66 $354,098 - $487,588
22,511 New
22,511 $421,000
Q3 2020

Nov 13, 2020

SELL
$13.54 - $26.41 $199,525 - $389,177
-14,736 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$7.84 - $23.29 $115,530 - $343,201
14,736 New
14,736 $343,000
Q3 2019

Nov 13, 2019

SELL
$9.17 - $12.01 $388,331 - $508,599
-42,348 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$10.88 - $17.6 $650,558 - $1.05 Million
-59,794 Reduced 58.54%
42,348 $503,000
Q1 2019

May 14, 2019

SELL
$15.51 - $17.61 $70,399 - $79,931
-4,539 Reduced 4.25%
102,142 $0
Q4 2018

Feb 13, 2019

SELL
$14.52 - $19.72 $39,174 - $53,204
-2,698 Reduced 2.47%
106,681 $1.85 Million
Q3 2018

Nov 02, 2018

SELL
$14.85 - $16.35 $42,886 - $47,218
-2,888 Reduced 2.57%
109,379 $1.63 Million
Q2 2018

Aug 08, 2018

SELL
$13.8 - $16.8 $259,688 - $316,142
-18,818 Reduced 14.36%
112,267 $1.79 Million
Q1 2018

May 03, 2018

SELL
$13.8 - $16.2 $85,849 - $100,780
-6,221 Reduced 4.53%
131,085 $1.86 Million
Q4 2017

Feb 02, 2018

BUY
$13.55 - $15.8 $1.86 Million - $2.17 Million
137,306
137,306 $1.92 Million

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.